Clinical Trials

NCT03849651 | ACTIVE_NOT_RECRUITING | PHASE2
69 participants

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2019-01-31
Completion:
2024-08-07
Conditions
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • NK-Cell Leukemia
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma (NHL)
  • Juvenile Myelomonocytic Leukemia (JMML)
  • Chronic Myeloid Leukemia (CML)
Interventions
  • DRUG
  • BIOLOGICAL
  • DEVICE
NCT03796884 | ACTIVE_NOT_RECRUITING | PHASE2
150 participants

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2019-10-30
Completion:
2026-09-30
Conditions
  • Colorectal Adenoma
  • Stage 0 Colorectal Cancer AJCC v8
  • Stage I Colorectal Cancer AJCC v8
  • Stage II Colorectal Cancer AJCC v8
  • Stage IIA Colorectal Cancer AJCC v8
  • Stage IIB Colorectal Cancer AJCC v8
  • Stage IIC Colorectal Cancer AJCC v8
  • Stage III Colorectal Cancer AJCC v8
  • Stage IIIA Colorectal Cancer AJCC v8
  • Stage IIIB Colorectal Cancer AJCC v8
  • Stage IIIC Colorectal Cancer AJCC v8
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT03687112 | COMPLETED
167191 participants

National Bank Alzheimer

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-22
Start Date:
2010-01-01
Completion:
2016-12-31
Conditions
  • Alzheimer Disease
Interventions
  • OTHER
No Results Yet
NCT03672331 | ACTIVE_NOT_RECRUITING | NA
53142 participants

My Personalized Breast Screening

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2019-07-18
Completion:
2027-08-31
Conditions
  • Breast Screening
Interventions
  • OTHER
No Results Yet
NCT03564340 | RECRUITING | PHASE1/PHASE2
890 participants

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2018-05-21
Completion:
2027-05-10
Conditions
  • Recurrent Ovarian Cancer
  • Recurrent Fallopian Tube Cancer
  • Recurrent Primary Peritoneal Cancer
  • Recurrent Endometrial Cancer
  • Endometrial Cancer
  • Low-grade Serous Ovarian Cancer
Interventions
  • DRUG
No Results Yet
NCT03269396 | SUSPENDED | NA
10 participants

Laryngeal Allograft Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2023-05-19
Completion:
2028-05-31
Conditions
  • Larynx Stenosis
  • Larynx Disease
  • Laryngectomy
  • Larynx
  • Larynx Fracture
Interventions
  • PROCEDURE
No Results Yet
NCT03065387 | TERMINATED | PHASE1
84 participants

Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-22
Start Date:
2017-10-31
Completion:
2026-04-23
Conditions
  • Advanced Malignant Solid Neoplasm
  • EGFR Gene Amplification
  • EGFR Gene Mutation
  • ERBB2 Gene Amplification
  • ERBB2 Gene Mutation
  • ERBB3 Gene Mutation
  • ERBB4 Gene Mutation
  • KRAS Gene Mutation
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page